Microbot Medical Inc. 8-K

What Happened
On March 24, 2026, Microbot Medical Inc. announced the publication of an article in the Journal of Vascular and Interventional Radiology (JVIR) titled “In Vivo Evaluation of a Disposable Endovascular Robotic System for Arterial Peripheral Vascular Interventions: A Multicenter Feasibility Study.” The article’s first author, Dr. Francois Cornelis, served as Lead Principal Investigator for the LIBERTY ACCESS PVI Pivotal Study. The company furnished the press release as Exhibit 99.1 to a Current Report on Form 8-K filed the same day under Regulation FD.

Key Details

• Filing date: March 24, 2026 (Form 8-K, Regulation FD disclosure).
• Publication: Article published in the Journal of Vascular and Interventional Radiology (JVIR).
• Study title: “In Vivo Evaluation of a Disposable Endovascular Robotic System for Arterial Peripheral Vascular Interventions: A Multicenter Feasibility Study.”
• Lead author / study role: Dr. Francois Cornelis — Lead Principal Investigator for the LIBERTY ACCESS PVI Pivotal Study.
• Press release is provided as Exhibit 99.1 to the 8-K.

Why It Matters
This filing publicly notifies investors that clinical results on Microbot’s disposable endovascular robotic system are now published in a peer-reviewed journal, increasing public access to the company’s clinical data. The Regulation FD disclosure indicates the company is making the information broadly available to the market. For investors, publication of clinical data and transparency around study leadership are relevant to assessing the company’s clinical progress and credibility in the vascular device space.